HI
IONS icon

Handelsinvest Investeringsforvaltning’s Ionis Pharmaceuticals IONS Stock Holding History

Handelsinvest Investeringsforvaltning’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$229K Sell
5,287
-2,746
-34% -$131K 0.11% 238
2023
Q4 		$406K Buy
+8,033
New +$385K 0.17% 178

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Handelsinvest Investeringsforvaltning's IONS Position: Q1 2024 in Review

Handelsinvest Investeringsforvaltning reduced its Ionis Pharmaceuticals (IONS) stake by 34% in Q1 2024, selling an estimated $131K and leaving 5,287 shares worth $229K. The position accounts for 0.11% of the portfolio, ranked #238.

Handelsinvest Investeringsforvaltning first reported a position in IONS in Q4 2023 and has held it in 2 quarters since. The position peaked at $406K in Q4 2023. 362 funds tracked by Wall St. Rank hold IONS as of Q1 2024.

  • Handelsinvest Investeringsforvaltning held 5,287 shares of Ionis Pharmaceuticals worth $229K as of Q1 2024.
  • Handelsinvest Investeringsforvaltning sold 2,746 Ionis Pharmaceuticals shares in Q1 2024, an estimated $131K.
  • Ionis Pharmaceuticals made up 0.11% of Handelsinvest Investeringsforvaltning's portfolio in Q1 2024, its #238 holding.
  • Handelsinvest Investeringsforvaltning first reported a position in Ionis Pharmaceuticals in Q4 2023 and has held it in 2 quarters since.
  • Handelsinvest Investeringsforvaltning's Ionis Pharmaceuticals position peaked at $406K in Q4 2023.
  • 362 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2024.

Based on Handelsinvest Investeringsforvaltning's 13F filing for Q1 2024, filed 19 Apr 2024.